Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Arora, Vineet
Yeh, Stephen
Variation in the HLA-G promoter region influences miscarriage rates.
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Adjuvant aromatase inhibitors: are we there yet?
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adjuvant aromatase inhibitors: are we there yet?
Adjuvant aromatase inhibitors: are we there yet? Cancer. 2003 Nov 01; 98(9):1779-81.
View in:
PubMed
subject areas
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Breast Neoplasms
Chemotherapy, Adjuvant
Clinical Trials as Topic
Disease-Free Survival
Enzyme Inhibitors
Female
Humans
Neoplasms, Hormone-Dependent
Nitriles
Tamoxifen
Triazoles
authors with profiles
Gini Fleming